Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Profit Margin (Quarterly): -2.60K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.60K% |
| March 31, 2024 | -15.12% |
| December 31, 2023 | -686.6% |
| September 30, 2023 | -294.9% |
| June 30, 2023 | -114.2% |
| March 31, 2023 | -89.71% |
| December 31, 2022 | -288.8% |
| September 30, 2022 | -210.7% |
| Date | Value |
|---|---|
| June 30, 2022 | -327.7% |
| March 31, 2022 | -134.3% |
| December 31, 2021 | -276.3% |
| September 30, 2021 | -314.6% |
| June 30, 2021 | -430.5% |
| March 31, 2021 | -267.8% |
| December 31, 2020 | -530.5% |
| September 30, 2020 | -456.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.60K%
Minimum
Jun 2024
-15.12%
Maximum
Mar 2024
-440.1%
Average
-291.8%
Median
Profit Margin (Quarterly) Benchmarks
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| Adaptimmune Therapeutics PLC | 54.22% |
| Verona Pharma PLC | -763.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.89% |
| Return on Assets | -29.98% |
| Return on Invested Capital | -69.89% |
| Gross Profit Margin (Quarterly) | -341.1% |
| Operating Margin (Quarterly) | -3.06K% |
| Return on Net Operating Assets | -112.5% |